Last reviewed · How we verify
THIAMINE HYDROCHLORIDE
At a glance
| Generic name | THIAMINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers (PHASE1)
- The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease (EARLY_PHASE1)
- Iron and Immune Response to Vaccine (IRONMUM) (NA)
- Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome (NA)
- Type 2 Diabetes and Blood Brain Barrier Improvement (EARLY_PHASE1)
- Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels (NA)
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- THIAMINE HYDROCHLORIDE CI brief — competitive landscape report
- THIAMINE HYDROCHLORIDE updates RSS · CI watch RSS